Labs at Duke and other academic centers collaborate to identify alternatives to antibiotics

Next generation protein engineering technology for improved drug candidate decision making

According to research firm Market Research Future (Pune, India), the global biomarker test market will reach $16 billion by 2022

Malvern Panalytical wins Innovate UK grant to lead biopharmaceutical consortium on aggregation analytics

Tuberculosis could be fought more effectively with future drugs—thanks to new research into an old antibiotic by University of Warwick and Francis Crick Institute

This year’s Simcyp Simulator enhancements include new oncology and preterm-birth populations, enhanced skin and gut transporter models, and additional regulatory qualification summaries

Research led by scientists at the University of Birmingham shows more precisely how G protein-coupled receptors, which are the key target of a large number of drugs, work

Selective C-H functionalization holds particular promise for the pharmaceutical industry

The technique is expected to find application not just in the pharmaceutical chemistry industry but also in a wide range of other chemical industries

A diabetes drug currently undergoing development could be repurposed to help end transplant rejection, without the side-effects of current immunosuppressive drugs